Connor, Clark & Lunn Investment Management (CC&L)
ISEE

Connor, Clark & Lunn Investment Management (CC&L)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-84,198
Closed -$2.05M – 1566
2023
Q1 		$2.05M Buy
84,198
+70,123
+498% +$1.54M 0.01% 545
2022
Q4 		$301K Sell
14,075
-412,675
-97% -$8.81M ﹤0.01% 976
2022
Q3 		$7.66M Buy
426,750
+82,644
+24% +$1.08M 0.05% 248
2022
Q2 		$3.31M Buy
344,106
+82,092
+31% +$1.03M 0.02% 389
2022
Q1 		$4.41M Buy
262,014
+7,885
+3% +$117K 0.02% 348
2021
Q4 		$4.25M Buy
+254,129
New +$4.17M 0.02% 361
2020
Q3 		– Sell
-424,138
Closed -$2.16M – 1171
2020
Q2 		$2.16M Sell
424,138
-211,981
-33% -$883K 0.02% 446
2020
Q1 		$2.19M Sell
636,119
-54,675
-8% -$320K 0.02% 398
2019
Q4 		$5.93M Sell
690,794
-84,465
-11% -$302K 0.04% 247
2019
Q3 		$868K Sell
775,259
-93,400
-11% -$109K 0.01% 572
2019
Q2 		$1.13M Sell
868,659
-6,695
-0.8% -$9.19K 0.01% 544
2019
Q1 		$1.23M Sell
875,354
-8,400
-1% -$11.7K 0.01% 490
2018
Q4 		$1.06M Buy
883,754
+1,867
+0.2% +$3.62K 0.01% 540
2018
Q3 		$2.08M Buy
881,887
+141,900
+19% +$354K 0.01% 426
2018
Q2 		$2.02M Buy
739,987
+330,226
+81% +$911K 0.01% 472
2018
Q1 		$1.12M Hold
409,761
– – 0.01% 468
2017
Q4 		$1.28M Sell
409,761
-108,103
-21% -$304K 0.01% 489
2017
Q3 		$1.46M Sell
517,864
-1,200
-0.2% -$3.24K 0.01% 469
2017
Q2 		$1.33M Buy
519,064
+178,575
+52% +$486K 0.01% 454
2017
Q1 		$1.25M Buy
+340,489
New +$1.44M 0.01% 463
2015
Q2 		– Sell
-7,000
Closed -$326K – 677
2015
Q1 		$326K Sell
7,000
-2,400
-26% -$125K ﹤0.01% 447
2014
Q4 		$422K Buy
+9,400
New +$395K ﹤0.01% 414

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ISEE Position: Q2 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 84,198 shares — an estimated $2.05M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ISEE in Q4 2014 and held it in 22 quarters. The position peaked at $7.66M in Q3 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 84,198 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $2.05M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 22 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s IVERIC bio, Inc. Common Stock position peaked at $7.66M in Q3 2022.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2023, filed 10 Aug 2023.